The following browsers support numerous web standards including CSS,XHTML, and the DOM (a universal means of controlling the behavior of web pages):
Please note that this is not intended be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
Robert G. Webster, Ph.D., F.R.S., has been selected to receive the Twelfth Annual Bristol-Myers Squibb Award for Distinguished Achievement in Infectious Diseases Research ...
Researchers at St. Jude Children's Research Hospital have demonstrated that it may be possible to improve treatment of autoimmune diseases like multiple sclerosis and prevent rejection of transplanted organs and tissues.
Arthur Nienhuis, M.D., and William Evans, Pharm.D., of St. Jude Children's Research Hospital have been elected to the Institute of Medicine, a prestigious branch of the National Academy of Sciences.
St. Jude Children's Research Hospital has competed for and will receive a multi-million dollar, five-year grant to expand its sickle cell disease program.
Researchers discovered that the c-Myc gene is essential for tumor development. They found that c-Myc is essential for the production and growth of blood vessels into tumors. Researchers were able to use this information to cut off the blood supply to tumors and thwart tumor growth.
Scientists have discovered that prestin, a cell membrane protein, is the motor protein that allows sound amplification crucial to mammalian hearing.
St. Jude researchers have been tracking a killer strain of influenza and have identified the strategy it used to slay its victims. A team of scientists discovered a protein that helps the virus avoid infection-fighting proteins produced by the body.
Ching-Hon Pui, M.D., of St. Jude Children's Research Hospital, has been named an American Cancer Society Clinical Research Professor.
William Evans, Pharm.D., will assume the newly created position of scientific director at St. Jude Children's Research Hospital Aug. 1.
Treatment with bone marrow mesenchymal cells, specialized bone-making cells, has the potential to enhance the therapeutic effects of bone marrow transplantation in patients with osteogenesis imperfecta (OI), also known as brittle bone disease.
Recent advances in the design of gene-therapy vectors offer promise for cancer patients who must receive chemotherapy, according to an article published in Nature Reviews Cancer.
Researchers discovered that infants treated for acute lymphoblastic leukemia (ALL) whose leukemic cells have a 11q23 chromosomal abnormality do not benefit from bone marrow transplantation. Research indicates that physicians treating these patients should rely on improved chemotherapy.
Interactions between the genes mutated in two different rare inherited disorders, Fanconi Anemia and Ataxia-Telangiectasia, provide new insights into tumor development and responses of tumors to therapy.
A rabbit liver protein can effectively activate the promising anti-cancer drug CPT-11, according to scientists at St. Jude Children's Research Hospital.
St. Jude researchers unveiled a genetic screening technique using microarray chops that should lead to dramatic improvements in diagnosing and treating ALL, and could lead to higher cure rates. The test is more than 95 percent accurate in diagnosing the known ALL subtypes and can identify new prognostic information.
A defective gene responsible for the death of nerve cells in the adult brain of mice has been identified, according to a study led by scientists at St. Jude Children's Research Hospital.
A method that enables scientists to study the development of an acute myeloid leukemia (AML) in mice should open new research paths for scientists studying cancer in humans.
Children with cancer and other serious illnesses often adapt to their conditions by repressing their emotions and covering up feelings of depression and anxiety, according to a new study published in January's Psychosomatic Medicine.
The effect of radiation on a child's brain has been measured for the first time in a pioneer study of pediatric brain tumor patients.